An Open-Label, Multicenter, Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1604 in Adults with Advanced Melanoma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511949-19-00

Acronym

SRP-21C101

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

2025-02-24

Last updated

2025-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Melanoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026